UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
January 30,
2007
Date of report (Date of earliest event reported)
APPLERA CORPORATION
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
001-04389
|
|
06-1534213 |
| (State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer |
| of Incorporation)
|
|
file number)
|
|
Identification No.) |
301 Merritt 7
Norwalk, Connecticut 06851
(Address of Principal Executive Offices, Including Zip Code)
(203) 840-2000
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
|
|
|
| Item 5.02 |
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers. |
(e) Stock Option Grants. On January 30, 2007, Applera Corporation (“Applera”) granted to some
of its officers and employees non-qualified stock options to purchase shares of Applera
Corporation-Applied Biosystems Group Common Stock (“AB stock”), pursuant to the Applera
Corporation/Applied Biosystems Group Amended and Restated 1999 Stock Incentive Plan (the “AB
Plan”), and non-qualified stock options to purchase Applera Corporation-Celera Group Common Stock
(“Celera stock”), pursuant to the Applera Corporation/Celera Group Amended and Restated 1999 Stock
Incentive Plan (the “Celera Plan”). These awards included options to purchase the following number
of shares of AB stock and Celera stock that were granted to Applera’s Chief Executive Officer
(principal executive officer) and Chief Financial Officer (principal financial officer), and other
officers that are within the Securities and Exchange Commission’s definition of Applera’s “named
executive officers”:
| |
|
|
|
|
|
|
|
|
| Officer |
|
Shares of AB Stock |
|
Shares of Celera Stock |
Tony L. White
|
|
|
196,000 |
|
|
|
84,000 |
|
Chairman, President
and Chief Executive Officer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kathy P.
Ordoñez
|
|
|
— |
|
|
|
150,000 |
|
Senior Vice President, and President,
Celera Group |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William B. Sawch
|
|
|
56,000 |
|
|
|
24,000 |
|
Senior Vice President and General Counsel
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dennis L. Winger
|
|
|
56,000 |
|
|
|
24,000 |
|
Senior Vice President and
Chief Financial Officer |
|
|
|
|
|
|
|
|
The options to purchase shares of AB stock granted on January 30 to these officers and
other employees have an exercise price of $34.6250 per share, which was the fair market value of AB
stock based on the average of the high and low sales price of AB stock on the New York Stock
Exchange on the grant date in accordance with the terms of the AB Plan. The options to purchase
shares of Celera stock granted on January 30 to these officers and other employees have an exercise
price of $15.3250 per share, which was the fair market value of Celera stock based on the average
of the high and low sales price of Celera stock on the New York Stock Exchange on the grant date in
accordance with the terms of the Celera Plan. These options have a term of 10 years from the grant
date, and become exercisable in four equal annual installments commencing on January 30, 2008, the
first anniversary of the grant date.